The study will include the recruitment of 1,020 participants from 10 gastroenterology departments of hospitals in Shanghai and Beijing. In the study, participants will be divided into three groups — erosive reflux disease, non-erosive reflux disease and control.
The study will examine the sensitivity in each of these groups and the efficacy of Peptest for diagnosing reflux.
More articles on GI/endoscopy:
Dr. Amar Naik joins Loyola University Health System
AGA to hold workshop on effective scope cleaning
15 gastroenterologist CEOs
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
